NSI-189

FDA Grants Orphan Drug Designation to Neuralstem's Treatment for Angelman Syndrome
CP Wire
Thu, 08/9/18 - 03:55 pm
Neuralstem
Angelman Syndrome
NSI-189
Neuralstem’s lead drug crumbles in PhII, adding to a litany of failures for depression drugs and blasting shares
Endpoints
Tue, 07/25/17 - 09:39 am
Neuralstem
clinical trials
NSI-189
clinical depression
An Early Valuation Of Neuralstem's NSI-189 For MDD
Seeking Alpha
Thu, 06/26/14 - 10:08 am
Neuralstem
NSI-189
major depressive disorder
Neuralstem: Sizing Up Potential Key Events Of 2014
Seeking Alpha
Tue, 01/28/14 - 11:09 am
Neuralstem
NSI-189
NSI-566
stem cells
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo
Mon, 04/22/13 - 11:05 am
FDA
Neuralstem
NSI-189
major depressive disorder
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo/AP
Wed, 10/17/12 - 11:54 am
FDA
Neuralstem
NSI-189
major depressive disorder